Bone mineral density in patients with inflammatory bowel disease: A population‐based prospective two‐year follow‐up study

References

• Andreassen H, Rungby J, Dahlerup JF, Mosekilde L. Inflammatory bowel disease and osteoporosis. Scand J Gastroenterol 1997; 32:1247–55.
   PubMed Web of Science ®Google Scholar
• Compston JE. Osteoporosis, corticosteroids and inflammatory bowel disease [review article]. Aliment Pharmacol Ther 1995;9: 237–50.
   PubMed Web of Science ®Google Scholar
• Schoon EJ, Wolffenbuttel BHR, Stockbrugger RW. Osteoporosis as a risk in inflammatory bowel disease. Drugs Today 1999;35: 17–28.
   Google Scholar
• Cino M, Greenberg GR. Bone mineral density in Crohn’s disease: a longitudinal study of budesonide, prednisone, and nonsteroid therapy. Am J Gastroenterol 2002;97:915–21.
   PubMed Web of Science ®Google Scholar
• Clements D, Motley RJ, Evans WD, Harries AD, Rhodes J, Coles RJ, et al. Longitudinal study of cortical bone loss in patients with inflammatory bowel disease. Scand J Gastroenterol 1992; 27: 1055–60.
   PubMed Web of Science ®Google Scholar
• Ulivieri FM, Piodi LP, Taioli E, Lisciandrano D, Ranzi T, Vezzoli M, et al. Bone mineral density and body composition in ulcerative colitis: a six-year follow-up. Osteoporos Int2001;12: 343–8.
   PubMedGoogle Scholar
• Klaus J, Armbrecht G, Steinkamp M, Bruckel J, Rieber A, Adler G, et al. High prevalence of osteoporotic vertebral fractures in patients with Crohn’s disease. Gut 2002;51:654–8.
   PubMed Web of Science ®Google Scholar
• Stockbrugger RW, Schoon EJ, Bollani S, Mills PR, Israeli E, Landgraf L, et al. Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn’s disease. Aliment Pharmacol Ther 2002;16:1519–27.
   PubMedGoogle Scholar
• Jahnsen J, Falch JA, Aadland E, Mowinckel P. Bone mineral density is reduced in patients with Crohn’s disease but not in patients with ulcerative colitis: a population-based study. Gut 1997;40:313–9.
   PubMed Web of Science ®Google Scholar
• Jahnsen J, Falch JA, Mowinckel P, Aadland E. Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol 2002; 37: 192–9.
   PubMed Web of Science ®Google Scholar
• Falch JA, Meyer HE. Bone mineral density measured by dual X-ray absorptiometry. Reference values in a Norwegian population. TidsskrNor Laegefor 1996;116:2299–302.
   PubMedGoogle Scholar
• Motley RJ, Crawley EO, Evans C, Rhodes J, Compston JE. Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease. Gut 1988;29:1332–6.
   Google Scholar
• Motley RJ, Clements D, Evans WD, Crawley EO, Evans C, Rhodes J, et al. A four-year longitudinal study of bone loss in patients with inflammatory bowel disease. Bone Miner 1993;23: 95–104.
   PubMedGoogle Scholar
• Staun M, Tjellesen L, Thale M, Schaadt O, Jarnum S. Bone mineral content in patients with Crohn’s disease. A longitudinal study in patients with bowel resections. Scand J Gastroenterol 1997;32:226–32.
   Google Scholar
• Roux C, Abitbol V, Chaussade S, Kolta S, Guillemant S, Dougados M, et al. Bone loss in patients with inflammatory bowel disease: a prospective study. Osteoporos Int 1995;5:156–60.
   PubMed Web of Science ®Google Scholar
• Ghosh S, Cowen S, Hannan WJ, Ferguson A. Low bone mineral density in Crohn’s disease, but not in ulcerative colitis, at diagnosis. Gastroenterology 1994;107:1031–9.
   PubMed Web of Science ®Google Scholar
• Schoon EJ, Bollani S, Mills P, Israeli E, Felsenberg D, Ljunghall S, et al. Budesonide versus prednisolone: effect on bone mineral density in patients with ileo-cecal Crohn’s disease. Gut 2002;51: A48.
   Google Scholar
• Bischoff SC, Herrmann A, Goke M, Manns MP, von zur Muhlen A, Brabant G. Altered bone metabolism in inflammatory bowel disease. Am J Gastroenterol 1997;92:1157–63.
   Google Scholar
• Robinson RJ, Iqbal SJ, Abrams K, Al-Azzawi F, Mayberry JF. Increased bone resorption in patients with Crohn’s disease. Aliment Pharmacol Ther 1998;12:699–705.
   PubMedGoogle Scholar
• Schoon EJ, Geerling BG, Van Dooren IM, Schurgers LJ, Vermeer C, Brummer RJ, et al. Abnormal bone turnover in long-standing Crohn’s disease in remission. Aliment Pharmacol Ther 2001;15:783–92.
   PubMedGoogle Scholar
• Dinca M, Fries W, Luisetto G, Peccolo F, Bottega F, Leone L, et al. Evolution of osteopenia in inflammatory bowel disease. Am J Gastroenterol 1999;94:1292–7.
   PubMed Web of Science ®Google Scholar
• Schulte C, Dignass AU, Mann K, Goebell H. Bone loss in patients with inflammatory bowel disease is less than expected: a follow-up study. Scand J Gastroenterol 1999;34:696–702.
   PubMed Web of Science ®Google Scholar
• Dresner-Pollak R, Karmeli F, Eliakim R, Ackerman Z, Rachmilewitz D. Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease. Am J Gastroenterol 2000;95: 699–704.
   Google Scholar
• Vogelsang H, Ferenci P, Resch H, Kiss A, Gangl A. Prevention of bone mineral loss in patients with Crohn’s disease by longterm oral vitamin D supplementation. Eur J Gastroenterol Hepatol 1995;7:609–14.
   Google Scholar
• von Tirpitz C, Klaus J, Bruckel J, Rieber A, Scholer A, Adler G, et al. Increase of bone mineral density with sodium fluoride in patients with Crohn’s disease. Eur J Gastroenterol Hepatol 2000; 12:19–24.
   PubMedGoogle Scholar
• Abitbol V, Mary JY, Roux C, Soule JC, Belaiche J, Dupas JL, et al. Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluoride. Aliment Pharmacol Ther 2002;16:919–27.
   PubMed Web of Science ®Google Scholar
• Haderslev KV, Tjellesen L, Sorensen HA, Staun M. Alendronate increases lumbar spine bone mineral density in patients with Crohn’s disease. Gastroenterology 2000;119:639–46.
   PubMedGoogle Scholar
• Clements D, Compston JE, Evans WD, Rhodes J. Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease. Gut 1993;34:1543–6.
   PubMed Web of Science ®Google Scholar
• Robinson RJ, Krzywicki T, Almond L, al-Azzawi F, Abrams K, Iqbal SJ, et al. Effect of a low-impact exercise program on bone mineral density in Crohn’s disease: a randomized controlled trial. Gastroenterology 1998;115:36–41.
   Google Scholar
• Driscoll RH, Jr, Meredith SC, Sitrin M, Rosenberg IH, Vitamin D. deficiency and bone disease in patients with Crohn’s disease. Gastroenterology 1982;83:1252–8.
   PubMed Web of Science ®Google Scholar
• Lamb EJ, Wong T, Smith DJ, Simpson DE, Coakley AJ, Moniz C, et al. Metabolic bone disease is present at diagnosis in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2002;16:1895–902.
   PubMedGoogle Scholar
• Silvennoinen J. Relationships between vitamin D, parathyroid hormone and bone mineral density in inflammatory bowel disease. J Intern Med 1996;239:131–7.
   PubMed Web of Science ®Google Scholar
• Andreassen H, Rix M, Brot C, Eskildsen P. Regulators of calcium homeostasis and bone mineral density in patients with Crohn’s disease. Scand J Gastroenterol 1998;33:1087–93.
   PubMed Web of Science ®Google Scholar
• Cowan FJ, Parker DR, Jenkins HR. Osteopenia in Crohn’s disease. Arch Dis Child 1995;73:255–6.
   PubMedGoogle Scholar
• Semeao EJ, Stallings VA, Peck SN, Piccoli DA. Vertebral compression fractures in pediatric patients with Crohn’s disease. Gastroenterology 1997;112:1710–3.
   PubMed Web of Science ®Google Scholar
• Thearle M, Horlick M, Bilezikian JP, Levy J, Gertner JM, Levine LS, et al. Osteoporosis: an unusual presentation of childhood Crohn’s disease. J Clin Endocrinol Metab 2000;85:2122–6.
   PubMed Web of Science ®Google Scholar
• Courtney AC, Wachtel EF, Myers ER, Hayes WC. Effects of loading rate on strength of the proximal femur. Calcif Tissue Int 1994;55:53–8.
   PubMed Web of Science ®Google Scholar
• Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. Br Med J 1996;312:L254–9.
   Google Scholar
• Jahnsen J, Falch JA, Mowinckel P, Aadland E. Ultrasound measurements of calcaneus for estimation of skeletal status in patients with inflammatory bowel disease. Scand J Gastroenterol 1999;34:790–7.
   PubMed Web of Science ®Google Scholar
• Scott EM, Gaywood I, Scott BB. Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology. Gut 2000;46 Suppl 1:i1–8.
   Google Scholar
• Valentine JF, Sninsky CA. Prevention and treatment of osteoporosis in patients with inflammatory bowel disease. Am J Gastroenterol 1999;94:878–83.
   PubMed Web of Science ®Google Scholar